Short answer
Jade Biosciences, Inc. (JBIO) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results released for quarter ended March 31, 2026.
Jade Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results released for quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1 with detailed financial results
- Filing signals a quarterly earnings update; investors should review Exhibit 99.1 for figures and guidance
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Jade Biosciences, Inc. 8-K filings
Get the next JBIO 8-K as it lands
Follow JBIO for push alerts, or ask the research agent what this filing means.